These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13848447)

  • 21. [Clinical evaluation of the anticoagulant, phenylindanedione].
    BUZZI A; CARBAJAL B
    Med Panam; 1958 Nov; 11(9-10):409-17. PubMed ID: 13632299
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing coronary intervention.
    Ragosta M; Karve M; Brezynski D; Humphries J; Sanders JM; Sarembock IJ; Gimple LW; Powers ER
    Am Heart J; 1999 Feb; 137(2):250-7. PubMed ID: 9924158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progressively acting antithrombins and plasma heparin resistance in ischemic heart disease].
    Barkagan ZS; Bishevskiĭ KM; Vidiakov GE; Kungurov IA
    Kardiologiia; 1981 Aug; 21(8):31-5. PubMed ID: 7289382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CLINICAL EXPERIENCES OF ANTICOAGULANT THERAPY: ASSOCIATION OF HEPARIN AND PHENYLINDANDIONE].
    SELVINI A; ROSSI C; GIRONI G
    Atti Accad Med Lomb; 1964; 19():41-6. PubMed ID: 14288064
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
    Novak M; Schlagenhauf A; Bernhard H; Schweintzger S; Leschnik B; Muntean W
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):588-92. PubMed ID: 21799400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased heparin resistance after operation measured by teh plasma heparin thrombin time.
    HOLGER-MADSEN T; SCHIOLER M
    Acta Chir Scand; 1960 Feb; 118():257-63. PubMed ID: 14402592
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion.
    Yao SK; McNatt J; Anderson HV; Eidt J; Cui KX; Golino P; Glas-Greenwalt P; Maraganore J; Buja LM; Willerson JT
    Am J Physiol; 1992 Feb; 262(2 Pt 2):H374-9. PubMed ID: 1539695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The endothelium and antithrombotic substances].
    Eber B
    Acta Med Austriaca; 1989; 16(5):102-4. PubMed ID: 2698051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-binding proteins are involved in thrombin time variability in normal and patient plasmas.
    Xiao H; Miller S; Faulk WP
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):455-60. PubMed ID: 10937807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CURRENT MYTHS AND REALITIES IN ANTICOAGULANT THERAPY FOR CORONARY HEART DISEASE.
    RUSSEK HI
    Med Clin North Am; 1964 Mar; 48():355-70. PubMed ID: 14149240
    [No Abstract]   [Full Text] [Related]  

  • 33. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EFFECT OF SUDDEN WITHDRAWAL OF LONG-TERM ANTICOAGULANT THERAPY ON THE HEPARIN RESISTANCE AND PLASMA FIBRINOGEN LEVEL.
    COTTON RC; WADE EG
    Clin Sci; 1964 Apr; 26():337-43. PubMed ID: 14162427
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct thrombin inhibitors (part 1 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Jan; 17(1):34-8. PubMed ID: 15640538
    [No Abstract]   [Full Text] [Related]  

  • 37. Anticoagulant effects of heparin in neonatal plasma.
    Schmidt B; Ofosu FA; Mitchell L; Brooker LA; Andrew M
    Pediatr Res; 1989 Apr; 25(4):405-8. PubMed ID: 2726317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A modified thrombin clotting time test as a quality control marker for heparin contamination in obstetric intraoperative cell salvage.
    Sullivan IJ; Hicks MK; Faulds JN; Carson PJ; Noble RS
    Transfus Med; 2012 Feb; 22(1):68-70. PubMed ID: 22171556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein-bound heparin/heparan sulfates in human adult and umbilical cord plasma.
    Xiao H; Miller SJ; Bang NU; Faulk WP
    Haemostasis; 1999; 29(4):237-46. PubMed ID: 10702706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
    Eidt JF; Allison P; Noble S; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    J Clin Invest; 1989 Jul; 84(1):18-27. PubMed ID: 2661588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.